Arrowhead Research | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ligand Pharmaceuticals USD 72.31M 8.69M 2024-12
Merck USD 13.24B 1.35B 2024-12
Moderna USD 1.62B 304M 2025-03
Novartis USD 8.87B 4.74B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
TG Therapeutics USD 179.89M 15.93M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 40.88M 11.84M 2024-12



Arrowhead Research Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.